Dr Varun Chaudhary discusses the impact of personalized treat-and-extend-based dosing on visual and anatomic outcomes of faricimab in the TENAYA and LUCERNE clinical trials in neovascular AMD.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.